Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 4,560 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: assessment only control Clear all

Conditions: Safety and Tolerability
Interventions: MDI-2517, Placebo; Drug · Other
Lead sponsor: MDI Therapeutics, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Overweight, Healthy
Interventions: LY3541105, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 21 Years to 65 Years
Enrollment: 206 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Lenexa, Kansas • San Antonio, Texas

Conditions: Infant Development, Language Development, Prematurity, Stress
Interventions: Music, Music and parent voice, Standard Care; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 24 Weeks to 30 Weeks
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 2
States / cities: New Haven, Connecticut • Boston, Massachusetts

Conditions: Colon Cancer Screening
Interventions: FITx3 intervention and CRC education, Colorectal Cancer (CRC) education alone; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 45 Years to 75 Years · Male only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Healthy Volunteer Study
Interventions: CBP-4888, Placebo; Drug · Other
Lead sponsor: Comanche Biopharma; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Sunscreen Agents
Interventions: BAY 987517, SPF 15 Control; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Union, New Jersey

Conditions: Chronic Pelvic Pain, Endometriosis
Interventions: My Pelvic Plan Website, Control Group website; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Satisfaction, Risk Reduction
Interventions: Study Group I, Study Group II, Control Group; Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Hypertension
Interventions: valsartan+amlodipine combination, valsartan, amlodipine; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 1,259 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Myopia, Myopia Progression, Juvenile Myopia
Interventions: Novel spectacle lens design, Spectacle lenses; Device
Lead sponsor: SightGlass Vision, Inc.; Industry
Eligibility: 9 Years to 14 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 6
States / cities: Longwood, Florida • Pittsburg, Kansas • Raytown, Missouri + 3 more

Conditions: Acquired Thrombotic Thrombocytopenic Purpura
Interventions: Caplacizumab, Placebo; Biological
Lead sponsor: Ablynx, a Sanofi company; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 13
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Atlanta, Georgia + 10 more

Conditions: Rehabilitation, ACL Reconstruction
Interventions: HOME, TNMT; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 13 Years to 30 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 4
States / cities: Flowery Branch, Georgia • Minneapolis, Minnesota • Rochester, Minnesota + 1 more

Conditions: Influenza, Human, Influenza, Human Flu
Interventions: Core letter signed by Surgeon General, Core letter signed by the Director of the National Vaccine Program, Core letter signed by Surgeon General + implementation prompt, Core letter signed by SG + enhanced implementation prompt; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 66 Years and older
Enrollment: 228,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Alcohol Dependence, Alcohol Abuse
Interventions: Motivational Interviewing, Spirit-Only Motivational Interviewing, Self-Change; Behavioral · Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: New York, New York

Conditions: Health Adult Subjects, Obesity & Overweight
Interventions: TIX100, Placebo; Drug
Lead sponsor: TIXiMED, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Intoxication Alcohol, Intoxication THC, Intoxication Combined Alcohol THC
Interventions: Dronabinol, Ethanol, Placebo dronabinol, Placebo ethanol; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 316 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease
Interventions: MEDI6012, Placebo SC, Placebo IV; Biological
Lead sponsor: MedImmune LLC; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 8
States / cities: Anniston, Alabama • Jacksonville, Florida • Port Orange, Florida + 5 more

Conditions: Breast Cancer, Cervical Cancer
Interventions: CLS Intervention, No CLS intervention; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 21 Years and older · Female only
Enrollment: 1,025 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Alcohol Abuse, Alcohol Use Disorder
Interventions: Stand-alone web-based cognitive behavioral therapy (CBT4CBT) for alcohol use disorder; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Heart Failure
Interventions: Inter-Atrial Shunt Device, Intracardiac Echo; Device · Other
Lead sponsor: Corvia Medical; Industry
Eligibility: 40 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2026
U.S. locations: 17
States / cities: Tucson, Arizona • New Haven, Connecticut • Chicago, Illinois + 11 more

Conditions: Osteoarthritis, Knee Pain
Interventions: SL-1002, Placebo; Drug
Lead sponsor: Saol Therapeutics Inc; Industry
Eligibility: 35 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 15
States / cities: Greenwood Village, Colorado • Washington D.C., District of Columbia • Coral Gables, Florida + 12 more

Conditions: Depression
Interventions: Supportive Therapy SSI, Behavioral Activation SSI, Growth Mindset SSI; Behavioral
Lead sponsor: Stony Brook University; Other
Eligibility: 13 Years to 16 Years
Enrollment: 2,452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Ebola Hemorrhagic Fever
Interventions: Placebo, AVI-6002; Drug
Lead sponsor: Sarepta Therapeutics, Inc.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Malaria
Interventions: MAM01 1.5 mg/kg, Placebo, MAM01 5 mg/kg, MAM01 10 mg/kg, MAM01 40 mg/kg, MAM01 450 mg, Control, MAM01 600 mg, MAM01 900 mg; Biological · Other
Lead sponsor: Gates Medical Research Institute; Other
Eligibility: 18 Years to 50 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants

A Study of LY3541105 in Healthy and Overweight Participants

The Impact of Music Medicine on Preterm Brain Development and Behavior

A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer

Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects

Sun Protection Factor (SPF) Assay

Novel Web-based, Self-directed Intervention for Chronic Pelvic Pain

Electronic Confirmed Versus Conventional Consenting Process: A Randomized Controlled Trial

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients

Spectacle Lens Visual Acuity Assessments Study

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Neuromuscular Intervention Targeted to Mechanisms of ACL Load in Female Athletes

Mail Outreach To Increase Vaccination Acceptance Through Engagement

Project Motion, A Study of Motivational Interviewing to Reduce Heavy or Problematic Drinking

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects

Using Imaging to Assess Effects of THC on Brain Activity

To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease

Using a Lay Health Worker Program to Increase Breast and Cervical Cancer Screening in Low-Income Hispanic Women

Integration of Neurofunctional Phenotyping Into Investigation of CBT4CBT for AUD

REDUCE LAP-HF RANDOMIZED TRIAL I

Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain

Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19

Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus

Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults